The Living Guidelines: UA/NSTEMI Recommendations for Anti Ischemic Therapy Polling Results for CLASS IIa Guidelines

Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, WikiDoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Class IIa Guidelines
1. It is reasonable to administer supplemental oxygen to all patients with UA/NSTEMI during the first 6 h after presentation. (Level of Evidence: C)

 UA/NSTEMI Guidelines Class IIa Recommendation 1 for Anti Ischemic Therapy should be: CLASS I CLASS IIa CLASS IIb CLASS III

2. In the absence of contradictions to its use, it is reasonable to administer morphine sulfate intravenously to UA/NSTEMI patients if there is uncontrolled ischemic chest discomfort despite NTG, provided that additional therapy is used to manage the underlying ischemia. (Level of Evidence: B)

 UA/NSTEMI Guidelines Class IIa Recommendation 2 for Anti Ischemic Therapy should be: CLASS I CLASS IIa CLASS IIb CLASS III

3. It is reasonable to administer intravenous (IV) beta blockers at the time of presentation for hypertension to UA/NSTEMI patients who do not have 1 or more of the following: a- Signs of HF, b- Evidence of a low-output state, c- Increased risk for cardiogenic shock, d- Other relative contraindications to beta blockade (PR interval >0.24 s, second or third degree heart block, active asthma, or reactive airway disease). (Level of Evidence: B)

 UA/NSTEMI Guidelines Class IIa Recommendation 3 for Anti Ischemic Therapy should be: CLASS I CLASS IIa CLASS IIb CLASS III

4. Oral long acting non dihydropyridine calcium antagonists are reasonable for use in UA/NSTEMI patients for recurrent ischemia in the absence of contraindications after beta blockers and nitrates have been fully used. (Level of Evidence: C)

 UA/NSTEMI Guidelines Class IIa Recommendation 4 for Anti Ischemic Therapy should be: CLASS I CLASS IIa CLASS IIb CLASS III

5. An ACE inhibitor administered orally within the first 24 h of UA/NSTEMI can be useful in patients without pulmonary congestion or LVEF ≤40% in the absence of hypotension (systolic blood pressure <100 mm Hg or less than 30 mm Hg below baseline) or known contraindications to that class of medications. (Level of Evidence: B)

 UA/NSTEMI Guidelines Class IIa Recommendation 5 for Anti Ischemic Therapy should be: CLASS I CLASS IIa CLASS IIb CLASS III

6. Intra aortic balloon pump (IABP) counter pulsation is reasonable in UA/NSTEMI patients for severe ischemia that is continuing or recurs frequently despite intensive medical therapy, for hemodynamic instability in patients before or after coronary angiography, and for mechanical complications of myocardial infarction MI. (Level of Evidence: C)

 UA/NSTEMI Guidelines Class IIa Recommendation 6 for Anti Ischemic Therapy should be: CLASS I CLASS IIa CLASS IIb CLASS III